MIF
WST icon

Mediolanum International Funds’s West Pharmaceutical WST Stock Holding History

Mediolanum International Funds’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.86M Buy
24,994
+6,877
+38% +$2.1M 0.08% 235
2026
Q1 		$4.44M Buy
18,117
+11,879
+190% +$2.96M 0.05% 284
2025
Q4 		$1.73M Sell
6,238
-243
-4% -$66.5K 0.02% 356
2025
Q3 		$1.69M Sell
6,481
-410
-6% -$99.6K 0.02% 357
2025
Q2 		$1.51M Buy
6,891
+1,093
+19% +$234K 0.02% 353
2025
Q1 		$1.29M Buy
5,798
+118
+2% +$32.5K 0.02% 355
2024
Q4 		$1.86M Sell
5,680
-581
-9% -$183K 0.02% 326
2024
Q3 		$1.94M Buy
6,261
+417
+7% +$128K 0.03% 337
2024
Q2 		$1.79M Buy
5,844
+190
+3% +$67.1K 0.03% 309
2024
Q1 		$2.23M Buy
+5,654
New +$2.09M 0.04% 291

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mediolanum International Funds's WST Position: Q2 2026 in Review

Mediolanum International Funds increased its West Pharmaceutical (WST) stake by 38% in Q2 2026, buying an estimated $2.1M and bringing the position to 24,994 shares worth $8.86M. The position accounts for 0.08% of the portfolio, ranked #235.

Mediolanum International Funds first reported a position in WST in Q1 2024 and has held it in 10 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Mediolanum International Funds held 24,994 shares of West Pharmaceutical worth $8.86M as of Q2 2026.
  • Mediolanum International Funds bought 6,877 West Pharmaceutical shares in Q2 2026, an estimated $2.1M.
  • West Pharmaceutical made up 0.08% of Mediolanum International Funds's portfolio in Q2 2026, its #235 holding.
  • Mediolanum International Funds first reported a position in West Pharmaceutical in Q1 2024 and has held it in 10 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.